RJA
SYK icon

Raymond James & Associates’s Stryker SYK Stock Holding History

Raymond James & Associates’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$262M Buy
724,533
+137,916
+24% +$47.6M 0.16% 106
2024
Q2 		$200M Sell
586,617
-4,599
-0.8% -$1.56M 0.13% 132
2024
Q1 		$212M Buy
591,216
+24,689
+4% +$8.31M 0.14% 125
2023
Q4 		$170M Buy
566,527
+3,310
+0.6% +$929K 0.13% 143
2023
Q3 		$154M Buy
563,217
+9,005
+2% +$2.58M 0.13% 150
2023
Q2 		$169M Sell
554,212
-25,466
-4% -$7.36M 0.14% 133
2023
Q1 		$165M Buy
579,678
+35,299
+6% +$9.37M 0.14% 129
2022
Q4 		$133M Buy
544,379
+20,440
+4% +$4.64M 0.12% 157
2022
Q3 		$106M Buy
523,939
+68,452
+15% +$14.4M 0.11% 175
2022
Q2 		$90.6M Buy
455,487
+47,904
+12% +$11.3M 0.09% 209
2022
Q1 		$109M Buy
407,583
+8,373
+2% +$2.17M 0.09% 194
2021
Q4 		$107M Buy
399,210
+1,711
+0.4% +$449K 0.09% 206
2021
Q3 		$105M Sell
397,499
-6,602
-2% -$1.77M 0.09% 195
2021
Q2 		$105M Buy
404,101
+10,560
+3% +$2.7M 0.1% 187
2021
Q1 		$95.9M Sell
393,541
-20,875
-5% -$5.01M 0.1% 181
2020
Q4 		$102M Buy
414,416
+27,271
+7% +$6.18M 0.11% 159
2020
Q3 		$80.7M Buy
387,145
+15,370
+4% +$2.99M 0.1% 169
2020
Q2 		$67M Buy
371,775
+24,267
+7% +$4.48M 0.09% 190
2020
Q1 		$57.9M Buy
347,508
+5,387
+2% +$1.05M 0.09% 182
2019
Q4 		$71.8M Buy
342,121
+23,591
+7% +$4.9M 0.09% 199
2019
Q3 		$68.9M Buy
318,530
+10,926
+4% +$2.34M 0.1% 195
2019
Q2 		$63.2M Buy
307,604
+11,093
+4% +$2.12M 0.09% 202
2019
Q1 		$58.6M Buy
296,511
+70,048
+31% +$12.6M 0.09% 216
2018
Q4 		$35.5M Buy
226,463
+4,345
+2% +$727K 0.06% 291
2018
Q3 		$39.5M Buy
222,118
+13,621
+7% +$2.33M 0.06% 293
2018
Q2 		$35.2M Buy
208,497
+31,946
+18% +$5.37M 0.06% 301
2018
Q1 		$28.4M Buy
176,551
+14,690
+9% +$2.37M 0.05% 356
2017
Q4 		$25.1M Buy
161,861
+7,399
+5% +$1.13M 0.05% 386
2017
Q3 		$21.9M Buy
154,462
+3,861
+3% +$554K 0.04% 415
2017
Q2 		$20.9M Buy
150,601
+12,856
+9% +$1.76M 0.05% 412
2017
Q1 		$18.1M Buy
137,745
+1,486
+1% +$188K 0.04% 432
2016
Q4 		$16.3M Buy
136,259
+2,194
+2% +$252K 0.04% 444
2016
Q3 		$15.6M Buy
134,065
+57,013
+74% +$6.64M 0.04% 436
2016
Q2 		$9.23M Buy
77,052
+21,455
+39% +$2.4M 0.03% 567
2016
Q1 		$5.97M Sell
55,597
-350
-0.6% -$34.5K 0.02% 740
2015
Q4 		$5.2M Buy
55,947
+2,631
+5% +$252K 0.02% 794
2015
Q3 		$5.02M Sell
53,316
-490
-0.9% -$48.5K 0.02% 754
2015
Q2 		$5.14M Buy
53,806
+113
+0.2% +$10.7K 0.02% 801
2015
Q1 		$4.95M Sell
53,693
-3,316
-6% -$309K 0.02% 747
2014
Q4 		$5.38M Buy
57,009
+1,872
+3% +$166K 0.03% 644
2014
Q3 		$4.45M Buy
55,137
+103
+0.2% +$8.47K 0.03% 687
2014
Q2 		$4.64M Sell
55,034
-184
-0.3% -$15K 0.03% 665
2014
Q1 		$4.5M Buy
55,218
+913
+2% +$72.6K 0.03% 620
2013
Q4 		$4.08M Buy
54,305
+1,620
+3% +$118K 0.03% 610
2013
Q3 		$3.56M Buy
52,685
+1,005
+2% +$69.4K 0.03% 610
2013
Q2 		$3.34M Buy
+51,680
New +$3.43M 0.03% 576

Other funds holding SYK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's SYK Position: Q3 2024 in Review

Raymond James & Associates increased its Stryker (SYK) stake by 24% in Q3 2024, buying an estimated $47.6M and bringing the position to 724,533 shares worth $262M. The position accounts for 0.16% of the portfolio, ranked #106.

Raymond James & Associates first reported a position in SYK in Q2 2013 and has held it in 46 quarters since. 2,033 funds tracked by Wall St. Rank hold SYK as of Q3 2024.

  • Raymond James & Associates held 724,533 shares of Stryker worth $262M as of Q3 2024.
  • Raymond James & Associates bought 137,916 Stryker shares in Q3 2024, an estimated $47.6M.
  • Stryker made up 0.16% of Raymond James & Associates's portfolio in Q3 2024, its #106 holding.
  • Raymond James & Associates first reported a position in Stryker in Q2 2013 and has held it in 46 quarters since.
  • 2,033 funds tracked by Wall St. Rank held Stryker as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.